New Avenue for Parkinson’s Disease Research
Nearly 60,000 Americans are diagnosed with Parkinson’s disease each year, resulting in a $52 Billion annual economic burden to the U.S. government. Parkinson’s disease is typified by the toxic aggregation of a presynaptic protein called alpha-Synuclein. Research published recently by the Mattoo lab shows a role for the human Fic protein, HYPE, in preventing aggregation of alpha-Synuclein. This novel link between HYPE and alpha-Synuclein opens exciting new avenues of research towards developing therapeutics for Parkinson’s disease.
Press Coverage links: